377 related articles for article (PubMed ID: 17140553)
1. Adiponectin actions in the cardiovascular system.
Hopkins TA; Ouchi N; Shibata R; Walsh K
Cardiovasc Res; 2007 Apr; 74(1):11-8. PubMed ID: 17140553
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection by adiponectin.
Ouchi N; Shibata R; Walsh K
Trends Cardiovasc Med; 2006 Jul; 16(5):141-6. PubMed ID: 16781946
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and interleukin-6 in inflammation-associated disease.
Li L; Wu LL
Vitam Horm; 2012; 90():375-95. PubMed ID: 23017723
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and cardiovascular disease.
Shibata R; Ouchi N; Murohara T
Circ J; 2009 Apr; 73(4):608-14. PubMed ID: 19261992
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and hypertension.
Ohashi K; Ouchi N; Matsuzawa Y
Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin: merely a bystander or the missing link to cardiovascular disease?
Hatzis G; Deftereos S; Tousoulis D; Bouras G; Giannopoulos G; Anatoliotakis N; Tsounis D; Stefanadis C
Curr Top Med Chem; 2013; 13(2):139-63. PubMed ID: 23470075
[TBL] [Abstract][Full Text] [Related]
8. The role of adiponectin in human vascular physiology.
Vaiopoulos AG; Marinou K; Christodoulides C; Koutsilieris M
Int J Cardiol; 2012 Mar; 155(2):188-93. PubMed ID: 21907426
[TBL] [Abstract][Full Text] [Related]
9. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
Kawano J; Arora R
J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
[TBL] [Abstract][Full Text] [Related]
10. Age and obesity-associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue.
Niemann B; Pan R; Teschner M; Boening A; Silber RE; Rohrbach S
Exp Gerontol; 2013 Jan; 48(1):55-63. PubMed ID: 22546364
[TBL] [Abstract][Full Text] [Related]
11. Potential of adiponectin as a cardioprotective agent.
Shibata R; Ouchi N; Walsh K; Murohara T
Future Cardiol; 2007 Nov; 3(6):647-56. PubMed ID: 19804285
[TBL] [Abstract][Full Text] [Related]
12. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin: an update.
Guerre-Millo M
Diabetes Metab; 2008 Feb; 34(1):12-8. PubMed ID: 18069030
[TBL] [Abstract][Full Text] [Related]
14. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
15. Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease.
Shinmura K
Heart Fail Rev; 2010 Sep; 15(5):457-66. PubMed ID: 20204504
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of the adiponectin pathway.
Gu W; Li Y
BioDrugs; 2012 Feb; 26(1):1-8. PubMed ID: 22050309
[TBL] [Abstract][Full Text] [Related]
17. Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes.
Morínigo R; Musri M; Vidal J; Casamitjana R; Delgado S; Lacy AM; Ayuso C; Gomis R; Corominola H
Obes Surg; 2006 Jun; 16(6):745-51. PubMed ID: 16756736
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin as an anti-inflammatory factor.
Ouchi N; Walsh K
Clin Chim Acta; 2007 May; 380(1-2):24-30. PubMed ID: 17343838
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
20. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
